Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]

BACKGROUND: Amyotrophic lateral sclerosis is a rapidly progressive neurodegenerative disorder characterised by loss of motor neurons leading to severe weakness and death from respiratory failure within 3-5 years. Riluzole prolongs survival in ALS. A published report has suggested a dramatic effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Chalabi, Ammar, Shaw, Pamela J, Young, Carolyn A, Morrison, Karen E, Murphy, Caroline, Thornhill, Marie, Kelly, Joanna, Steen, I Nicholas, Leigh, P Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189869/
https://www.ncbi.nlm.nih.gov/pubmed/21936930
http://dx.doi.org/10.1186/1471-2377-11-111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189869/
https://www.ncbi.nlm.nih.gov/pubmed/21936930
http://dx.doi.org/10.1186/1471-2377-11-111

Ejemplares similares